suMMARY In 2 patients with phaeochromocytoma, effective beta-blockade was obtained with propranolol (40 mg twice a day for 3 days) or acebutolol (400 mg twice a day for 3 days) without any effect on the blood pressure. In both patients the excretion of noradrenaline predominated over that of adrenaline, a picture found in most cases of phaeochromocytoma. A hypertensive response to beta-blockade might be expected in patients with an adrenaline-secreting tumour. It cannot be a regular event or constitute a diagnostic test in patients with suspected phaeochromocytoma.
Beta-adrenergic blockade can unmask the alphavasoconstrictor action of adrenaline in man (Vlachakis et al., 1977) . A hypertensive effect of propranolol has been described in phaeochromocytoma (Prichard and Ross, 1966 ). Yet neither acebutolol nor propranolol had any effect on the blood pressure in 2 of our patients with phaeochromocytoma.
Out of 16 consecutive patients with phaeochromocytoma, 9 had been given beta-blockers before phaeochromocytoma was diagnosed (propranolol in 6, acebutolol in 2, and oxprenolol in 1). None of the 9 patients reported an increase in symptoms related to hypertension, and no evidence of increased blood pressure was reported in their records. Accurate data were available in the following 2 cases.
Case reports
A 38-year-old woman was referred on account of a blood pressure of 190/124 mmHg. She had had episodic nausea and headache for 13 years. Antihypertensive therapy was stopped a month before admission to hospital for complete investigation. This included urinary screening for catecholamines and a therapeutic test with acebutolol in which blood pressure, heart rate, and plasma renin activity were measured after 3 days on placebo and 3 days on acebutolol 400 mg twice a day (Menard et al., 1976) . Beta-blockade by acebutolol decreased the heart rate by 20 per cent and the plasma renin activity by 78 per cent but had no effect on the blood pressure (Fig) . Phaeochromocytoma was diagnosed from the 24-hour urinary excretion of vanillylmandelic acid (46 mmol), metanephrinee (2395 mg), noradrenaline (6413 nmol), and adrenalins (224 nmol). Angiography showed a mass in the right adrenal. A phaeochromocytoma weighing 25 g was removed and thereafter the patient was normotensive.
A 49-year-old man was referred because of high blood pressure, 210/132 mmHg. His hypertension was asymptomatic and untreated. Investigations included a therapeutic test with propranolol 40 mg twice a day conducted as described above for acebutolol. After 3 days on propranolol, the heart rate decreased by 20 per cent, and plasma renin activity by 90 per cent, but the blood pressure was unchanged ( Fig.) . The 24-hour urinary excretion of vanillylmandelic acid, metanephrines, nonadrenaline, and adrenaline was 46 mmol, 1190 mg, 728 nmol, and 6 nmol, respectively. A phaeochromocytoma was removed from the left adrenal and the patient became normotensive.
Discussion
A potential danger of beta-blockade in patients with phaeochromocytoma is the paradoxical rise in blood pressure linked to 'adrenaline reversal': Dornhorst and Laurence (1963) Wark and Larkins (1978) , pulmonary oedema followed several days or weeks after the introduction of propranolol, but in neither patient was the blood pressure raised.
In our patients the effectiveness of beta-blockade was shown by a consistent decrease in heart rate and plasma renin activity. The absence of a fall in blood pressure in response to beta-blockade suggests that the renin-angiotensin system was not contributory in maintaining the hypertension. The absence of a rise in blood pressure is at variance with the suggestion of Prichard and Ross (1966) . A possible explanation for this discrepancy in our first patient is her having had a beta-l receptor antagonist, acebutolol, whereas the patients of Prichard and Ross had propranolol: in normal volunteers, Johnsson (1975) found the mean blood pressure was decreased during adrenaline infusion, unchanged during infusion of adrenaline with metoprolol (another beta-l receptor antagonist), and increased during infusion of adrenaline with propranolol. A more likely explanation in both our patients is the dominance of noradrenaline over adrenaline production, since it has been shown in hypertensive men that beta-blockade does not modify the pressor response to noradrenaline (Vlachakis et al., 1977) .
Beta-blockers are widely used in the treatment of hypertension, and their prescription in patients with unsuspected phaeochromocytoma cannot be a rare event. Their administration to such patients without previous alpha-blockade might be harmful where adrenaline is the predominating catecholamine; where noradrenaline predominates it would merely be useless. Fortunately, noradrenaline is the dominant or the sole catecholamine in the tumour and in the urine of most patients with phaeochromocytoma: this was the case in 30 of the 35 patients of von Euler and Strom (1957) , and in all the 24 patients of Crout and Sjoerdsma (1964) .
In patients with suspected phaeochromocytoma, the vasopressor response to propranolol is not an appropriate diagnostic test. Beta-blockers may be useful in prevention and treatment of tachycardia. They should not be used before alpha-adrenergic blockade when the tumour produces a significant amount of adrenaline. 
